← Back to Search

Behavioral Intervention

Parentese Speech for Autism

N/A
Recruiting
Led By Pumpki L. Su, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Has uncorrected visual impairment or hearing impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 300 ms after the target words are introduced
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to find out if using a special way of talking called parentese, in both video and live interactions, can help children with autism learn new words. It also wants to see what factors

Who is the study for?
This trial is for children with Autism or related neurodevelopmental disorders. It aims to see if a special way of speaking called 'parentese' helps them learn new words. Children must have a diagnosis of autism to join.
What is being tested?
The study tests whether parentese speech, either from videos (Aim 1) or live interaction (Aim 2), can help autistic children learn new words better than regular adult speech.
What are the potential side effects?
There are no direct physical side effects expected from this trial as it involves language learning through observation and interaction rather than medication.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have vision or hearing problems that haven't been corrected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~300 ms after the target words are introduced
This trial's timeline: 3 weeks for screening, Varies for treatment, and 300 ms after the target words are introduced for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of time during which children's eye gaze is directed toward the target object

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ParenteseExperimental Treatment1 Intervention
All participants will learn novel words in two conditions (parentese vs adult register) in each of the experiment (video and live word learning). In the Parentese condition, participants will listen to sentences that contain novel words in parentese.
Group II: Adult RegisterActive Control1 Intervention
All participants will learn novel words in two conditions (parentese vs adult register) in each of the experiment (video and live word learning). In the Adult Register condition, participants will listen to sentences that contain novel words in adult register speech.

Find a Location

Who is running the clinical trial?

The University of Texas at DallasLead Sponsor
67 Previous Clinical Trials
108,007 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,958 Total Patients Enrolled
Pumpki L. Su, PhDPrincipal InvestigatorUniversity of Texas at Dallas
~67 spots leftby Mar 2028